Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia

CONCLUSION:

Y-QA31 is a selective D3R antagonist that exhibits antipsychotic effects in some animal models with positive symptoms and cognitive disorder and less extrapyramidal side effects.

2 Likes

I thought schizophrenia was purely a human condition. Though I guess animals can still exhibit symptoms of it that medication would help. Maybe I just read the title wrong and it only looks to me like it’s implying animals get it too.

its 4 positive symptoms of sz…